Arterial stiffness and endothelial dysfunction in HIV-infected children
- 1 April 2004
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 18 (7) , 1037-1041
- https://doi.org/10.1097/00002030-200404300-00012
Abstract
The role of antiretroviral therapy in acceleration of atherosclerosis in HIV-infected adults is controversial, partly because of the confounding effects of the involvement of classic cardiovascular risk factors. To study vascular function in HIV-infected children. Cross-sectional study of 49 HIV-infected children (34 receiving antiretroviral therapy and 15 never treated) and if 24 age- and sex-matched controls. Automatic, computerized, ultrasonic procedure evaluation of geometric and mechanical properties of the common carotid artery, and of the endothelium-dependent dilation and endothelium-independent dilation. Relative systolodiastolic variations in diameter of the carotid artery in HIV-infected children were significantly lower than those in controls, but there was no significant difference in intima-media thickness. Cross-sectional compliance and distensibility were also significantly lower. Wall stiffness, assessed as the incremental elastic modulus, was larger in HIV-infected children. Endothelium-dependent dilation was lower in HIV-infected children but non-endothelium-dependent dilation was similar to that in controls. We did not find differences for any of the vascular variables between HIV-infected children receiving antiretroviral therapy and those never treated. All arterial variables were similar in children with and without dyslipidemia. HIV-infected children had a vascular dysfunction in the absence of cardiovascular risk factors. In this short series, no additional detrimental effects were observed after a mean of 5 years of antiretroviral therapy.Keywords
This publication has 18 references indexed in Scilit:
- Carotid Intima-Media Thickness in Heavily Pretreated HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Cardiovascular and Cerebrovascular Events in Patients Treated for Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 2003
- Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitorsAtherosclerosis, 2002
- Efficacy of highly active antiretroviral therapy in HIV-1 infected childrenThe Lancet Infectious Diseases, 2002
- Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective studyThe Lancet, 2001
- Metabolic Abnormalities in HIV Type 1-Infected Children Treated and Not Treated with Protease InhibitorsAIDS Research and Human Retroviruses, 2001
- Use of Human Immunodeficiency Virus-1 Protease Inhibitors Is Associated With Atherogenic Lipoprotein Changes and Endothelial DysfunctionCirculation, 2001
- Adverse effects of antiretroviral therapyThe Lancet, 2000
- Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected childrenAIDS, 2000
- Plasma Cholesterol and Triglyceride Distributions in 13,665 Children and Adolescents: the Prevalence Study of the Lipid Research Clinics ProgramPediatric Research, 1980